SCHEMBL7344381

SCHEMBL7344381

CCOC(=O)CN(Cc1cc2c(cc1Cl)OCO2)S(=O)(=O)c1ccc(OC)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.58
KEAP1 Q14145 1/20 0.48
MAPT P10636 3/20 0.47
HPGD P15428 3/20 0.46
TSHR P16473 3/20 0.46
TAS2R14 Q9NYV8 1/20 0.43
LMNA P02545 2/20 0.43
NPSR1 Q6W5P4 2/20 0.43
MAPK1 P28482 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
USP2 O75604 1/20 0.43
GAA P10253 1/20 0.43
BMP1 P13497 3/20 0.42
MMP1 P03956 2/20 0.42
MMP8 P22894 2/20 0.42
POLB P06746 1/20 0.42
CA2 P00918 1/20 0.41
MMP2 P08253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7340819 0.88 KEAP1 (0.64) ALDH1A1KEAP1MAPTHPGDTSHR
SCHEMBL7342188 0.85 MMP3 (0.58) ALDH1A1KEAP1MAPTHPGDBMP1
SCHEMBL22252122 0.80 KEAP1 (0.73) ALDH1A1KEAP1TSHRTAS2R14LMNA
SCHEMBL7350174 0.78 ALDH1A1 (0.81) ALDH1A1KEAP1TAS2R14BMP1
SCHEMBL8008261 0.77 ALDH1A1 (0.73) ALDH1A1TAS2R14LMNANPSR1MEN1
SCHEMBL5093686 0.75 ALDH1A1 (0.72) ALDH1A1KEAP1TSHRTAS2R14LMNA
SCHEMBL7342014 0.73 ALDH1A1 (0.64) ALDH1A1KEAP1TAS2R14MAPK1BMP1
SCHEMBL7344978 0.72 BMP1 (0.57) BMP1MMP1MMP8
SCHEMBL7344980 0.72 BMP1 (0.57) BMP1MMP1MMP8
SCHEMBL7000836 0.71 BMP1 (0.69) ALDH1A1MAPTTAS2R14BMP1MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0606046-B1 Arylsulfonamido-substituted hydroxamic acids CIBA GEIGY AG (CH) 1997-10-08 EP disclosed
US-5646167-A ADMINISTERED AS METALLOPROTEINASE INHIBITOR, ANTITUMOR OR ANTICARCINOGENIC AGENT CIBA-GEIGY CORPORATION (US) 1997-07-08 US disclosed
US-5552419-A METALLOPROTEINASE INHIBITORS CIBA-GEIGY CORPORATION (US) 1996-09-03 US disclosed
US-5506242-A METALLOELASTASE INHIBITOR; TREATS EMPHYSEMA CIBA-GEIGY CORPORATION (US) 1996-04-09 US disclosed
US-5455258-A Useful as inhibitors of matrix-degrading metalloproteinase enzymes such as stromelysin and/or collegenase CIBA-GEIGY CORPORATION (US) 1995-10-03 US disclosed
EP-0606046-A1 Arylsulfonamido-substituted hydroxamic acids CIBA-GEIGY AG (CH) 1994-07-13 EP disclosed